Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 19, 2003, Pages 3301-3303

  Segall, Yoffi ^a,b   Quistad, Gary B ^a   Nomura, Daniel K ^a   Casida, John E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLSULFONYL FLUORIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CHOLINESTERASE; FATTY ACID AMIDASE; METHYLARACHIDONYLFLUOROPHOSPHONATE; N (2 HYDROXYETHYL)ARACHIDONYLSULFONAMIDE; NEUROTOXIC ESTERASE; UNCLASSIFIED DRUG;

AGONIST; ARTICLE; BINDING AFFINITY; BRAIN; DRUG BINDING; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; INHIBITION KINETICS;

EID: 0042832959     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00721-2     Document Type: Article

References (18)

1. Devane W.A., Hanuš L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Science. 258:1992;1946.
2. Ross R.A., Brockie H.C., Fernando S.R., Saha B., Razdan R.K., Pertwee R.G. Br. J. Pharmacol. 125:1998;1345.
3. Deutsch D.G., Omeir R., Arreaza G., Salehani D., Prestwich G.D., Huang Z., Howlett A. Biochem. Pharmacol. 53:1997;255.
4. Fernando S.R., Pertwee R.G. Br. J. Pharmacol. 121:1997;1716.
5. Deutsch D.G., Lin S., Hill W.A.G., Morse K.L., Salehani D., Arreaza G., Omeir R.L., Makriyannis A. Biochem. Biophys. Res. Commun. 231:1997;217.
6. Martin B.R., Beletskaya I., Patrick G., Jefferson R., Winckler R., Deutsch D.G., Di Marzo V., Dasse O., Mahadevan A., Razdan R.K. J. Pharmacol. Exp. Ther. 294:2000;1209.
7. Suhara Y., Takayama H., Nakane S., Miyashita T., Waku K., Sugiura T. Chem. Pharm. Bull. 48:2000;903.
8. Easton C.J., Xia L., Pitt M.J., Ferrante A., Poulos A., Rathjen D.A. Synthesis. 2001;451.
9. +): 337. 2201, found: 337. 2199.
10. +):356. 2185 found: 356. 2195.
11. +): 397.2651 found: 397.2658.
12. Quistad G.B., Sparks S.E., Casida J.E. Toxicol. Appl. Pharmacol. 173:2001;48.
13. Segall Y., Quistad G.B., Casida J.E. Synth. Commun. 33:2003;2151.
14. 14C]oleic acid liberated by hydrolysis according to ref 12.
15. 3H]CP 55,940 (10 nM). After incubation for 90 min at 30 °C, CB1-bound radiolabel was recovered by vacuum filtration for quantification. Potential hydrolysis of 1 and 4 by FAAH was examined and minimized by assaying with PMSF (50 μM, 15-min pre-incubation) or alone. Assay conditions of Quistad, G. B.; Nomura, D. K.; Sparks, S. E.; Segall, Y.; Casida, J. E. Toxicol. Lett. 2002, 135, 89.
16. Quistad G.B., Sparks S.E., Segall Y., Nomura D.K., Casida J.E. Toxicol. Appl. Pharmacol. 179:2002;57.
17. Assays according to refs 12 and 16.
18. 3)F] according to Seltzman, H. H.; Fleming, D. N.; Deutsch, D. G.; Glaser, S. T.; Stevenson, L.; Ross, R.; Pertwee, R. G. Abstracts of Papers, 2001 Symposium on the Cannabinoids, International Cannabinoid Research Society: Burlington, VT, 2001.